Developing Countries: An Evolving Opportunity for Oncologic Research

Badwe, Rajendra A.; D'cruz, Anil K.; Mistry, Rajesh C.; Tongaonkar, Hemant B.; Shastri, Surendra; Thorat, Mangesh
July 2006
World Journal of Surgery;Jul2006, Vol. 30 Issue 7, p1173
Academic Journal
The article discusses the potential of developing countries in contributing knowledge for oncologic research. Oncologic incidence in developed and developing countries were in contrast in incidence and survival rates. Lower incidence and survival rates of cancer in developing countries reveals oncologic research opportunities in fields such as testing technology, biologic insights and indigenous medicine.


Related Articles

  • Seven research projects urged for countries with limited resources. Ra'ad, Dina // JNCI: Journal of the National Cancer Institute;10/2/96, Vol. 88 Issue 19, p1343 

    Provides information on seven research projects related to cancer research in developing countries. Sponsor of the initiative; Priority research areas; Grassroots approach to cancer research.

  • THE ANALYSIS OF UNDIAGNOSED MALIGNANCIES. Kleina, Regina; Franckevica, Ivanda; Sperga, Maris; Lutinska, Daina // Papers on Anthropology;2011, Vol. 20, p199 

    Among the pathology methods autopsy is also a valuable tool in evaluating diagnostic accuracy in oncology. Malignancies are undiagnosed due to the lack of some laboratory investigations, the absence of specific symptoms of cancers and the delayed treatment of them. The aim is to analyze the...

  • Research & Markets: Cardiac Medical Devices - This Emerging Markets Report Forecasts the Market to Reach US$11.9 Bln by 2015.  // Biomedical Market Newsletter;3/31/2011, p607 

    The article offers information on the addition of GlobalData's new report entitled "Brain Cancer Global Clinical Trials Review, Q4 2010" which tackles on the clinical scenario of brain cancer, clinical trials and trial development in developing countries.

  • Use of Geriatric Assessment for Older Adults in the Oncology Setting: A Systematic Review. Puts, M. T. E.; Hardt, J.; Monette, J.; Girre, V.; Springall, E.; Alibhai, S. M. H. // JNCI: Journal of the National Cancer Institute;Aug2012, Vol. 104 Issue 15, p1134 

    Background Geriatric assessment is a multidisciplinary diagnostic process that evaluates the older adult’s medical, psychological, social, and functional capacity. No systematic review of the use of geriatric assessment in oncology has been conducted. The goals of this systematic review...

  • Mechanisms of acquired resistance to cetuximab: role of HER (ErbB) family members. Wheeler, D. L.; Huang, S.; Kruser, T. J.; Nechrebecki, M. M.; Armstrong, E. A.; Benavente, S.; Gondi, V.; Hsu, K.-T.; Harari, P. M. // Oncogene;6/26/2008, Vol. 27 Issue 28, p3944 

    The epidermal growth factor receptor (EGFR) is a central regulator of proliferation and progression in human cancers. Five EGFR inhibitors, two monoclonal antibodies and three TKIs, have recently gained FDA approval in oncology (cetuximab, panitumumab, erlotinib, gefitinib and lapatinib). These...

  • Hospital A.C.Camargo. Soares, Fernando Augusto // BMC Proceedings;2013, Vol. 7 Issue Suppl 2, pA3 

    The article offers information on the Hospital A.C.Camargo, which is a private nonprofit making institute, and states that the hospital is one of the world's biggest cancer treatment, teaching and oncology research center. It states that the more than 15 thousand patients from different parts of...

  • Peritonealkarzinose kolorektalen Ursprungs. Weber, T.; Roitman, M.; Link, K.H. // Der Chirurg;Feb2013, Vol. 84 Issue 2, p130 

    Until recently peritoneal carcinomatosis (PC) arising from colorectal cancer (CRC) was considered to be a terminal disease manifestation. Despite palliative systemic chemotherapy (CHT) the majority of patients died within a few months. Nowadays cytoreductive surgery (CRS) of the peritoneal...

  • Role of nurses in the assessment and management of chemotherapy-related side effects in cancer patients. Roe, Helen; Lennan, Elaine // Nursing: Research & Reviews;2014, Vol. 4, p103 

    Chemotherapy services in the UK have been the subject of national policy directives for the past decade. These directives, amongst other things, include the development of nurseled services; however, progress has been slow. This paper looks at the evidence for nurse-led services and discusses...

  • Investigating urachal carcinoma for more than 15 years. DUQUN CHEN; YIFAN LI; ZUHU YU; ZHENGMING SU; LIANGCHAO NI; YAOTING GUI; SHANGQI YANG; BENTAO SHI; YONGQING LAI // Oncology Letters;2014, Vol. 8 Issue 5, p2279 

    Urachal carcinomas are rare bladder malignances, which usually present at an advanced stage with a high risk of distant metastases and a poor prognosis. To improve understanding of this uncommon carcinoma, a retrospective review was conducted for the cases observed at Peking University Shenzhen...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics